Target intelligence / Profile preview

Cytochrome b (CYTB) (CYTB)

Target
CYTB
Molecular classification
Enzyme, Oxidoreductase, Mitochondrial protein
01

Overview

Cytochrome b is a critical transmembrane protein component of the mitochondrial cytochrome bc1 complex (Complex III), which is essential for the survival of various protozoan parasites, most notably Plasmodium falciparum (UniProt: Q02768) [1]. It functions as an oxidoreductase within the electron transport chain, facilitating the transfer of electrons from ubiquinol to cytochrome c while pumping protons across the inner mitochondrial membrane to maintain the membrane potential [2]. In parasites like Plasmodium, this process is uniquely vital because the electron transport chain provides the oxidized ubiquinone required by dihydroorotate dehydrogenase (DHODH) for de novo pyrimidine biosynthesis [3]. Since these parasites cannot salvage pyrimidines from the host, inhibition of cytochrome b leads to a cessation of DNA synthesis and parasite death [2]. The drug atovaquone is a potent inhibitor that targets the ubiquinol oxidation (Qo) site of the parasite's cytochrome b [4]. However, the therapeutic efficacy of such inhibitors is frequently compromised by the rapid emergence of resistance, often resulting from single nucleotide polymorphisms in the mitochondrial cytochrome b gene [1, 4].

Other names
Mitochondrial cytochrome bUbiquinol-cytochrome c reductase cytochrome b subunitComplex III subunit 3Cytb
02

Mechanism of action

Inhibition of the ubiquinol oxidation (Qo) site of the cytochrome bc1 complex, disrupting the mitochondrial electron transport chain and preventing the regeneration of ubiquinone required for pyrimidine biosynthesis.

03

Biological functions

Electron transport chainMitochondrial respirationPyrimidine biosynthesis
04

Disease associations

InfectionMalariaToxoplasmosisBabesiosis
05

Safety considerations

Rapid development of drug resistanceSelectivity over host mitochondrial complex III
06

Interacting drugs

Atovaquone

4 more in the full profile.

07

Biomarkers

Cytochrome b gene mutations (e.g., Y268S, Y268N)

Beyond the preview

Go deeper on Cytochrome b (CYTB) (CYTB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome b (CYTB) (CYTB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call